BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. Common Stock
Your view on BHST
Overview
What the company does, where it operates, and who runs it.
About BioHarvest Sciences Inc. Common Stock
- Industry
- Agricultural - Commodities/Milling
- Sector
- Industrials
- CEO
- Ilan Sobel
- Headquarters
- CA
- Industry
- Agricultural - Commodities/Milling
- Sector
- Industrials
- CEO
- Ilan Sobel
- Headquarters
- CA
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.
The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products.
Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for BioHarvest Sciences Inc. Common Stock, and the rating behind it. BHST last traded at $1.85; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for BioHarvest Sciences Inc. Common Stock. Starting points for BioHarvest Sciences Inc. Common Stock: EPS -$0.49, beta 1.36 — an Agricultural - Commodities/Milling name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for BioHarvest Sciences Inc. Common Stock. BioHarvest Sciences Inc. Common Stock does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for BioHarvest Sciences Inc. Common Stock. Trailing twelve-month EPS for BioHarvest Sciences Inc. Common Stock stands at -$0.49. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for BioHarvest Sciences Inc. Common Stock. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
BioHarvest Sciences Inc. Common Stock valued side by side against its closest peers. BioHarvest Sciences Inc. Common Stock is measured against Agricultural - Commodities/Milling peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold BioHarvest Sciences Inc. Common Stock, and how their positions are changing. At a $32.1M market value, institutional positions materially move BioHarvest Sciences Inc. Common Stock's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by BioHarvest Sciences Inc. Common Stock executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming BioHarvest Sciences Inc. Common Stock. BioHarvest Sciences Inc. Common Stock is a $32.1M Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming BioHarvest Sciences Inc. Common Stock. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for BioHarvest Sciences Inc. Common Stock. Coverage tracks BioHarvest Sciences Inc. Common Stock within Agricultural - Commodities/Milling (Industrials). Press releases and market coverage, newest first.